Refine your search
Collections
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Rishipathak, Dinesh
- Insulin Therapies:Current and Future Trends
Abstract Views :563 |
PDF Views:0
Authors
Affiliations
1 MET’S Institute of Pharmacy, Bhujbal Knowledge City, Adgaon, Nashik-422003, Savitribai Phule Pune University, IN
1 MET’S Institute of Pharmacy, Bhujbal Knowledge City, Adgaon, Nashik-422003, Savitribai Phule Pune University, IN
Source
Asian Journal of Research in Pharmaceutical Sciences, Vol 7, No 4 (2017), Pagination: 189-196Abstract
Many patients with advanced type 2 diabetes mellitus (T2DM) and all patients with T1DM require insulin to keep blood glucose levels in the target range. The most common route of insulin administration is subcutaneous insulin injections. There are many ways to deliver insulin subcutaneously such as vials and syringes, insulin pens, and insulin pumps. Though subcutaneous insulin delivery is the standard route of insulin administration, it is associated with injection pain, needle phobia, lipodystrophy, noncompliance and peripheral hyperinsulinemia. Therefore, the need exists for delivering insulin in a minimally invasive or noninvasive and in most physiological way. Inhaled insulin was the first approved noninvasive and alternative way to deliver insulin, but it has been withdrawn from the market. Technologies are being explored to make the noninvasive delivery of insulin possible. Some of the routes of insulin administration that are under investigation are oral, buccal, nasal, peritoneal and transdermal. This review article focuses on the various insulin delivery techniques. This article has focused on different possible routes of insulin administration with its advantages and limitation and possible scope for the new drug development.Keywords
Diabetes Mellitus, Inhaled Insulin, Insulin Delivery, Oral Insulin, Technology, Closed-Loop System, Artificial Pancreas.References
- Garg, S. K., et al. (2013). Use of non-insulin therapies for type 1 diabetes, Mary Ann Liebert, Inc. 140 Huguenot Street, 3rd Floor New Rochelle, NY 10801 USA.
- Group, U. P. D. S. (1995). "UK Prospective Diabetes Study 16: overview of 6 years' therapy of type II diabetes: a progressive disease." Diabetes 44(11): 1249-1258.
- Yaturu, S. (2013). "Insulin therapies: current and future trends at dawn." World J Diabetes 4(1): 1-7.
- Rima B. Shah1, M. P., David M. Maahs, Viral N. Shah (2016). "Insulin delivery methods: Past, present and future " International Journal of Pharmaceutical Investigation 6(1).
- Fry, A. (2012). "Insulin Delivery Device Technology 2012: where are we after 90 years?" Journal of Diabetes Science and Technology 6(4): 947-953.
- Penfornis, A., et al. (2011). "Evolution of devices in diabetes management." Diabetes Technology & Therapeutics13(S1): S-93-S-102.
- Shah, R. B., et al. (2016). "Insulin delivery methods: Past, present and future." International Journal of Pharmaceutical Investigation 6(1): 1.
- Cohen, O., et al. (2009). "Improved glycemic control through continuous glucose sensor-augmented insulin pump therapy: prospective results from a community and academic practice patient registry." Journal of Diabetes Science and Technology 3(4): 804-811.
- Burdick, P., et al. (2009). "Use of a subcutaneous inj ction port to improve glycemic control in children with type 1 diabetes." Pediatric Diabetes10(2): 116-119.
- Shah, V. N., et al. (2014). Closed-loop system in the management of diabetes: past, present, and future, Mary Ann Liebert, Inc. 140 Huguenot Street, 3rd Floor New Rochelle, NY 10801 USA.
- Predicting the Anti-Inflammatory Activity of Novel 5-Phenylsulfamoyl-2-(2-Nitroxy) (Acetoxy) Benzoic Acid Derivatives using 2D and 3D-QSAR (kNN-MFA) Analysis
Abstract Views :502 |
PDF Views:0
Authors
Affiliations
1 Department of Pharmaceutical Chemistry, Bhujbal Knowledge City, MET’S IOP, Adgaon, Nashik-422003, IN
1 Department of Pharmaceutical Chemistry, Bhujbal Knowledge City, MET’S IOP, Adgaon, Nashik-422003, IN
Source
Asian Journal of Research in Pharmaceutical Sciences, Vol 7, No 4 (2017), Pagination: 227-234Abstract
The quantitative structure–activity relationship (QSAR) analyses were carried out for a series of new side chain modified 5-phenylsulfamoyl-2-(2-nitroxy) (acetoxy) benzoic acid derivatives to find out the structural requirements of their anti-inflammatory activities. The statistically significant best 2D QSAR models for anti-inflammatory activity having correlation coefficient (r2) = 0.897 and cross validated squared correlation coefficient (q2) = 0.701 with external predictive ability (pred_r2) = 0.390 were developed by multiple linear regression coupled with genetic algorithm (GA–MLR) and stepwise (SW–MLR) forward algorithm, respectively. The results of the present study may be useful on the designing of more potent analogues as antimalarial agents.Keywords
QSAR, 5-Phenylsulfamoyl-2-(2-Nitroxy) (Acetoxy) Benzoic Acid, Anti-Inflammatory, MLR, Genetic Algorithm.References
- H. Abadi, et al. (2005), Synthesis of novel 4-substituted-7-trifluoromethylquinoline derivatives with nitric oxide releasing properties and their evaluation as analgesic and anti-inflammatory agents, Bioorganic and Medicinal Chemistry , 13, pp. 5759–5765.
- U. K. Bandarage, et al. (2000) Nitrosothiol esters of diclofenac synthesis and pharmacological characterization as gastrointestinal-sparing prodrugs, Journal of Medicinal Chemistry, 43, pp. 4005-16.
- S. V. Bhandari, et al. (2009) Design, synthesis and pharmacological screening of novel nitric oxide donors containing 1,5-diarylpyrazolin-3-one as nontoxic NSAIDs, European Journal of Medicinal Chemistry, 44, pp.4622–4636
- Ajmani, S., Jadhav, K., and Kulkarni, S. (2006), Three-dimensional QSAR using the k-nearest neighbor method and its interpretation. Journal of chemical information and modeling, 46, pp. 24-31.
- BOLTON, S. and BON, C. (2004), Pharmaceutical Statistics- Practical and Clinical Application 4th Ed. New York, USA: Marcel Dekker Inc.
- C. Cena, et al. (2003) Anti-inflammatory, Gastro sparing, and Antiplatelet Properties of New NO-Donor Esters of Aspirin, Journal of Medicinal Chemistry, 46, pp. 747- 54.
- M. A. Chowdhury, et al. (2010), Celecoxib analogs possessing a N-(4-nitrooxybutyl) piperidin-4-yl or N-(4- nitrooxybutyl)-1,2,3,6-tetrahydropyridin-4-yl nitric oxide donor moiety: Synthesis, biological evaluation and nitric oxide release studies, Bioorganic and Medicinal Chemistry Letters , 20, pp.1324–1329
- M. A. Chowdhury, et al. (2008), Synthesis of new 4-[2-(4-methyl (amino) sulfonylphenyl)-5-trifluoromethyl-2H-pyrazol-3-yl]-1, 2, 3, 6-tetrahydropyridines: A search for novel nitric oxide donor anti-inflammatory agents, Bioorganic and Medicinal Chemistry, 16, pp.8882–88
- B. C. Daniel, et al. (2008), Non-steroidal Anti-inflammatory Agents – Benefits and New Developments for Cancer Pain, Supportive Oncology, pp. 18-22.
- J. E Downing, et a.l (2005) Gastric and thymic assay of acute oral treatment of rats with nitric oxide esters of ibuprofen or indomethacin, Biochem. Biophys. Res. Commun.
- O. O. Fadeyi, et al (2004) Antipyretic, analgesic, anti-inflammatory and cytotoxic effects of four derivatives of salicylic acid and anthranilic acid in mice and rats, African Journal of Biotechnology, 3(8), pp. 426-431
- S. Fiorucci, J. L. Wallace, R. N. Dubois, et al.(2000) New anti-inflammatory agents: NO-NSAIDS and COX-2 inhibitors. International conference on “Advances in Prostaglandin and Leukotriene Research: Basic Science and New Clinical Applications”, June (4-8), pp. 2.
- S. Fioruccia, et al. (2007), NSAIDs, coxibs, CINOD and H2S-releasing NSAIDs: What lies beyond the horizon, Digestive and Liver Disease, 39, pp. 1043–1051.